A tissue microRNA signature that predicts the prognosis of breast cancer in young women
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A tissue microRNA signature that predicts the prognosis of breast cancer in young women
Authors
Keywords
MicroRNAs, Breast cancer, Microarrays, Biomarkers, Cancer treatment, Prognosis, Cancer detection and diagnosis, Surgical and invasive medical procedures
Journal
PLoS One
Volume 12, Issue 11, Pages e0187638
Publisher
Public Library of Science (PLoS)
Online
2017-11-16
DOI
10.1371/journal.pone.0187638
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Young adult breast cancer patients have a poor prognosis independent of prognostic clinicopathological factors: a study from the Japanese Breast Cancer Registry
- (2016) Akemi Kataoka et al. BREAST CANCER RESEARCH AND TREATMENT
- Absolute Benefit of Adjuvant Endocrine Therapies for Premenopausal Women With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Early Breast Cancer: TEXT and SOFT Trials
- (2016) Meredith M. Regan et al. JOURNAL OF CLINICAL ONCOLOGY
- MiRNA-183-5p promotes cell proliferation and inhibits apoptosis in human breast cancer by targeting the PDCD4
- (2016) Yan Cheng et al. Reproductive Biology
- Identification of a circulating microRNA signature to distinguish recurrence in breast cancer patients
- (2016) Dezheng Huo et al. Oncotarget
- Hsa-miR-375 is a predictor of local control in early stage breast cancer
- (2016) Franz Zehentmayr et al. Clinical Epigenetics
- MicroRNA-194 is a Marker for Good Prognosis in Clear Cell Renal Cell Carcinoma
- (2016) Roy Nofech-Mozes et al. Cancer Medicine
- High expression of microRNA-183/182/96 cluster as a prognostic biomarker for breast cancer
- (2016) Cailu Song et al. Scientific Reports
- Breast cancer statistics, 2015: Convergence of incidence rates between black and white women
- (2015) Carol E. DeSantis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)
- (2015) Claudia Allemani et al. LANCET
- Gene expression in “young adult type” breast cancer: a retrospective analysis
- (2015) Rebecca H. Johnson et al. Oncotarget
- Epigenetic silencing of miR-375 induces trastuzumab resistance in HER2-positive breast cancer by targeting IGF1R
- (2014) Xing-Ming Ye et al. BMC CANCER
- A Serum MicroRNA Signature Predicts Tumor Relapse and Survival in Triple-Negative Breast Cancer Patients
- (2014) K. Kleivi Sahlberg et al. CLINICAL CANCER RESEARCH
- Metastatic breast cancer in young women: a population-based cohort study to describe risk and prognosis
- (2014) A. Tjokrowidjaja et al. INTERNAL MEDICINE JOURNAL
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Prospective Study of Fertility Concerns and Preservation Strategies in Young Women With Breast Cancer
- (2014) Kathryn J. Ruddy et al. JOURNAL OF CLINICAL ONCOLOGY
- A Prognostic Model of Triple-Negative Breast Cancer Based on miR-27b-3p and Node Status
- (2014) Songjie Shen et al. PLoS One
- miR-205 acts as a tumour radiosensitizer by targeting ZEB1 and Ubc13
- (2014) Peijing Zhang et al. Nature Communications
- Prognostic Significance of Metastasis-Related MicroRNAs in Early Breast Cancer Patients with a Long Follow-up
- (2013) A. Markou et al. CLINICAL CHEMISTRY
- Increased expression of miR-126 and miR-10a predict prolonged relapse-free time of primary oestrogen receptor-positive breast cancer following tamoxifen treatment
- (2013) Reiner Hoppe et al. EUROPEAN JOURNAL OF CANCER
- Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
- (2013) Antonio C. Wolff et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinicopathological features of young patients (
- (2013) Akemi Kataoka et al. Breast Cancer
- Early discontinuation of tamoxifen intake in younger women with breast cancer: Is it time to rethink the way it is prescribed?
- (2012) Laetitia Huiart et al. EUROPEAN JOURNAL OF CANCER
- Biological and prognostic associations of miR-205 and let-7b in breast cancer revealed by in situ hybridization analysis of micro-RNA expression in arrays of archival tumour tissue
- (2012) John Le Quesne et al. JOURNAL OF PATHOLOGY
- Re-expression of microRNA-375 reverses both tamoxifen resistance and accompanying EMT-like properties in breast cancer
- (2012) A Ward et al. ONCOGENE
- Modulation of MicroRNA-194 and Cell Migration by HER2-Targeting Trastuzumab in Breast Cancer
- (2012) Xiao-Feng Le et al. PLoS One
- MicroRNA expression analysis in triple-negative (ER, PR and Her2/neu) breast cancer
- (2011) Jelena Radojicic et al. CELL CYCLE
- A New Molecular Predictor of Distant Recurrence in ER-Positive, HER2-Negative Breast Cancer Adds Independent Information to Conventional Clinical Risk Factors
- (2011) Martin Filipits et al. CLINICAL CANCER RESEARCH
- Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group
- (2011) M. Dowsett et al. JNCI-Journal of the National Cancer Institute
- Prognostic Significance of Young Age (
- (2011) Eun-Kyu Kim et al. WORLD JOURNAL OF SURGERY
- Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (
- (2010) G. Cancello et al. ANNALS OF ONCOLOGY
- Dysregulated miR-183 inhibits migration in breast cancer cells
- (2010) Aoife J Lowery et al. BMC CANCER
- Epigenetically Deregulated microRNA-375 Is Involved in a Positive Feedback Loop with Estrogen Receptor in Breast Cancer Cells
- (2010) P. de Souza Rocha Simonini et al. CANCER RESEARCH
- A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor-Positive Breast Cancer
- (2010) T. O. Nielsen et al. CLINICAL CANCER RESEARCH
- Relationship between age at diagnosis and outcome of premenopausal breast cancer: age less than 35 years is a reasonable cut-off for defining young age-onset breast cancer
- (2009) Wonshik Han et al. BREAST CANCER RESEARCH AND TREATMENT
- Young Age at Diagnosis Correlates With Worse Prognosis and Defines a Subset of Breast Cancers With Shared Patterns of Gene Expression
- (2008) Carey K. Anders et al. JOURNAL OF CLINICAL ONCOLOGY
- An Array-Based Analysis of MicroRNA Expression Comparing Matched Frozen and Formalin-Fixed Paraffin-Embedded Human Tissue Samples
- (2008) Xiao Zhang et al. JOURNAL OF MOLECULAR DIAGNOSTICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search